«Mathematical modeling can identify ways to limit
aggressive tumor cell growth.»
Not exact matches
An experimental drug in early development for
aggressive brain
tumors can cross the blood - brain
tumor barrier, kill
tumor cells and block the
growth of
tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
In this study, we found that chloroquine not only has an effect on the
growth of the cancer
cells, but also makes the
tumor environment less
aggressive by normalizing the abnormal blood vessels in the
tumor,» says Patrizia Agostinis.
They found that, by using math models to understand the complex dynamics within cancers, they could use small changes in the environment to promote the
growth of
cells that are less
aggressive and thereby decrease
tumor growth.
In the new study, published online March 27, 2018, in
Cell Reports, a team led by UCSF's David Raleigh, MD, PhD, found that increased activity of a gene known as FOXM1 appears to be responsible for the
aggressive growth and frequent recurrence of these
tumors.
Many women are «triple negative» No one yet knows precisely why, but African - American women are roughly twice as likely as white women to have triple - negative breast cancer — so called because
tumor cells in this particularly
aggressive form of the disease test negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal
growth factor receptor 2 (HER - 2).
Studies show that human cancer
cells express high levels of the fatty acid synthase enzyme, which is associated with
aggressive tumor behavior and
tumor -
cell growth.
Blocking Hemangiosarcoma
Tumor Growth Hemangiosarcoma, a malignant cancer of blood vessel
cells, is an
aggressive disease that is rapidly fatal in dogs.